Endocannabinoids as Guardians of Metastasis
AbstractEndocannabinoids including anandamide and 2-arachidonoylglycerol are involved in cancer pathophysiology in several ways, including tumor growth and progression, peritumoral inflammation, nausea and cancer pain. Recently we showed that the endocannabinoid profiles are deranged during cancer to an extent that this manifests in alterations of plasma endocannabinoids in cancer patients, which was mimicked by similar changes in rodent models of local and metastatic cancer. The present topical review summarizes the complexity of endocannabinoid signaling in the context of tumor growth and metastasis. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Tegeder, I. Endocannabinoids as Guardians of Metastasis. Int. J. Mol. Sci. 2016, 17, 230.
Tegeder I. Endocannabinoids as Guardians of Metastasis. International Journal of Molecular Sciences. 2016; 17(2):230.Chicago/Turabian Style
Tegeder, Irmgard. 2016. "Endocannabinoids as Guardians of Metastasis." Int. J. Mol. Sci. 17, no. 2: 230.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.